Pilot Safety Study of Injectable SIS for Critical Limb Ischemia

NCT02145845 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2017-12-21

No results posted yet for this study

Summary

This study is intended to collect safety and effectiveness data on the Cook Injectable Small Intestinal Submucosa (SIS)

Conditions

  • Critical Limb Ischemia
  • Peripheral Arterial Disease
  • Peripheral Vascular Disease

Interventions

DEVICE

Injectable SIS

Injectable SIS

Sponsors & Collaborators

  • Cook Group Incorporated

    lead INDUSTRY

Principal Investigators

  • Vaclav Prochazka, MD · University Hospital Ostrava

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2017-06-05
Completion
2017-11-06

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02145845 on ClinicalTrials.gov